Literature DB >> 1611087

Clonal analysis of myelodysplastic syndrome: monosomy 7 is expressed in the myeloid lineage, but not in the lymphoid lineage as detected by fluorescent in situ hybridization.

W R Gerritsen1, J Donohue, J Bauman, S C Jhanwar, N A Kernan, H Castro-Malaspina, R J O'Reilly, J H Bourhis.   

Abstract

Conflicting results have been published on whether or not myelodysplastic syndromes (MDS) affect all cell lineages. Involvement of myeloid and erythroid cell lineages has been regularly observed, but it remains controversial whether the different lymphoid cell lineages are involved. In this study of eight patients with MDS associated with monosomy 7, fluorescent in situ hybridization (FISH) was used to enumerate the chromosomes 7 in interphase cells. With the probe D7Z1, the rate of false-positive detection of monosomy 7 was 3% +/- 2% in normal cells. T- and B-cell lines were established from eight patients with MDS and monosomy 7. As determined by FISH in interphase cells, 1.9% (0% to 3%) of the cells in the B-cell lines showed one fluorescent spot and 1.1% (0% to 2.9%) of the cells in the T-cell lines. These values do not differ from normal values. However, the possibility that normal cells were selected when the T- and B-cell lines were established could not be excluded. Therefore, peripheral blood cells were obtained, separated according to surface markers specific for lymphoid and myeloid cell lineage with a cell sorter, and analyzed for the expression of monosomy 7 by FISH. Antibodies recognizing T cells (CD3), B cells (CD20), natural killer (NK) cells (CD57), monocytes and granulocytes (low and high expression of CD11b antigen), and myeloid progenitors (CD33) were used to separate cells. The expression of monosomy 7 in the T cells, NK cells, and B cells did not differ from control values. These results in the lymphoid subpopulations are in stark contrast with the observations in the myeloid populations; the percentage of cells with monosomy 7 ranged from 9% to 78% (controls: 6% +/- 2%) in cells with low CD11b expression, 20% to 89% in cells with a high expression of the CD11b antigen (controls: 7% +/- 3%), and 23% to 91% in the CD33 positive cells (controls: 5% +/- 3%). The results of this study suggest that monosomy 7 does not usually affect lymphoid subpopulations but is restricted to committed progenitor cells with the capacity to differentiate into mature myeloid cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1611087

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  15 in total

1.  Therapy-related acute myeloid leukemia 6 years after clonal detection of inv(11)(q21q23) and MLL gene rearrangement.

Authors:  Naoko Takei; Kazumi Suzukawa; Harumi Yamamoto Mukai; Takayoshi Itoh; Yasushi Okoshi; Yasuhiro Yoda; Toshiro Nagasawa
Journal:  Int J Hematol       Date:  2006-04       Impact factor: 2.490

2.  Genomic landscape of CD34+ hematopoietic cells in myelodysplastic syndrome and gene mutation profiles as prognostic markers.

Authors:  Lan Xu; Zhao-Hui Gu; Yang Li; Jin-Li Zhang; Chun-Kang Chang; Chun-Ming Pan; Jing-Yi Shi; Yang Shen; Bing Chen; Yue-Ying Wang; Lu Jiang; Jing Lu; Xin Xu; Jue-Ling Tan; Yu Chen; Sheng-Yue Wang; Xiao Li; Zhu Chen; Sai-Juan Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-21       Impact factor: 11.205

3.  Gain of chromosome 1q portends worse prognosis in multiple myeloma despite novel agent-based induction regimens and autologous transplantation.

Authors:  Gunjan L Shah; Heather Landau; Dory Londono; Sean M Devlin; Satyajit Kosuri; Alexander M Lesokhin; Nikoletta Lendvai; Hani Hassoun; David J Chung; Guenther Koehne; Suresh C Jhanwar; Ola Landgren; Ross Levine; Sergio A Giralt
Journal:  Leuk Lymphoma       Date:  2017-01-12

4.  Establishment of a monosomy 7 leukemia cell line, MONO-7, with a ras gene mutation.

Authors:  Hiroyuki Fujisaki; Kenji Takai; Sawada Akihisa; Sadao Tokimasa; Yoshiko Matsuda; Hideaki Ohta; Yuko Osugi; Ji Yoo Kim; Gaku Hosoi; Masahiro Sako; Junichi Hara
Journal:  Int J Hematol       Date:  2002-01       Impact factor: 2.490

5.  CD4 deficiency in myelodysplastic syndrome with monosomy 7.

Authors:  C M Weemaes; F Preijers; G A de Vaan; J A Bakkeren; I S Klasen; A Haraldsson
Journal:  Eur J Pediatr       Date:  1996-02       Impact factor: 3.183

Review 6.  Biology and treatment of myelodysplastic syndromes--developments in the past decade.

Authors:  R Willemze; W E Fibbe; J H Falkenburg; J C Kluin-Nelemans; P M Kluin; J E Landegent
Journal:  Ann Hematol       Date:  1993-03       Impact factor: 3.673

7.  Interphase Chromosome Flow-FISH.

Authors:  Keyvan Keyvanfar; Jason Weed; Prashanth Swamy; Sachiko Kajigaya; Rodrigo T Calado; Neal S Young
Journal:  Blood       Date:  2012-08-29       Impact factor: 22.113

Review 8.  The pur protein family: genetic and structural features in development and disease.

Authors:  Edward M Johnson; Dianne C Daniel; Jennifer Gordon
Journal:  J Cell Physiol       Date:  2013-05       Impact factor: 6.384

Review 9.  Clonality in the myelodysplastic syndromes.

Authors:  Jacqueline Boultwood; James S Wainscoat
Journal:  Int J Hematol       Date:  2001-06       Impact factor: 2.490

10.  A NUP98-HOXD13 fusion gene impairs differentiation of B and T lymphocytes and leads to expansion of thymocytes with partial TCRB gene rearrangement.

Authors:  Chul Won Choi; Yang Jo Chung; Christopher Slape; Peter D Aplan
Journal:  J Immunol       Date:  2009-10-19       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.